Cloud infrastructure is the fastest growing segment fueling the growth of High Content Screening Market

 

The global High Content Screening Market is estimated to be valued at US$ 1,847.2 Mn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
High Content Screening (HCS) is an automated imaging and analysis technique that enables researchers in life sciences to observe biological functions within live cells in a multi-parametric manner. HCS helps to study cell biology and detect the activity of various compounds for applications such as drug discovery. It provides advanced data analysis capabilities by quantifying a variety of parameters relevant to cell health and function.

Market key trends:
The growing adoption of cloud-based high content screening solutions is one of the major trends witnessed in the global market. Cloud infrastructure provides numerous advantages such as reduced capital investment, easy data storage & access, scalability, and improved collaboration. The rising need to analyze large volumes of imaging data generated during various drug discovery and cell biology research studies in a cost-effective manner is propelling the demand for cloud HCS solutions. Cloud platforms facilitate data sharing and analysis between research institutes located worldwide, thus speeding up the research process.
Segment Analysis
The global high content screening market is segmented on the basis of product, applications, end-use and region. Based on product, instruments segment dominated the market in 2022 owing to its wide applications in drug discovery, primary and secondary screening, toxicity studies, and other life science research. Instruments segment is further sub-segmented into cell imaging and analysis systems, flow cytometry, liquid handling systems and consumables. Consumables sub-segment is expected to witness highest growth during the forecast period due to continuous requirement of reagents, assay kits, microplates and other consumables in high content screening processes.

Key Takeaways
The global high content screening market size is expected to reach US$ 1,847.2 Mn by 2030 from US$ 891.2 Mn in 2023, expanding at a CAGR of 5.8% from 2023 to 2030. The market is projected to witness high growth driven by increasing R&D investments in pharmaceutical and biotechnology industries and growing therapeutic applications of high content screening systems.

Regional analysis - North America dominated the global high content screening market in 2022 and is expected to continue its dominance during the forecast period. This is attributed to presence of major players, increasing biopharmaceutical research activities, and technological advancements in the region. Asia Pacific exhibited fastest growth and is estimated to expand at highest CAGR during the analysis period owing to improving healthcare infrastructure, rising medical tourism, and growing investments by key players.

Key players analysis - Key players operating in the high content screening market are Becton, Dickinson and Company, Thermo Fisher Scientific Inc., GE HealthCare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher, Yokogawa Electric Corporation, Sysmex Corporation, and Thorlabs, Inc. Major players are focusing on new product launches, mergers, acquisitions and geographic expansions to consolidate their market positions.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more